Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-15 Sale |
2021-11-17 4:18 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
30,000 | $114.5 | $3,435,099 | 401,351 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:03 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $115.16 | $575,800 | 288,448 (Direct) |
View |
| 2021-08-19 Sale |
2021-08-23 4:24 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
25,000 | $92.68 | $2,317,102 | 436,351 (Direct) |
View |
| 2021-05-12 Sale |
2021-05-14 6:02 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
25,000 | $92.69 | $2,317,366 | 461,351 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-05 5:48 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
18,986 | $89.28 | $1,695,006 | 179,618 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 4:04 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $119.18 | $595,900 | 158,604 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 4:22 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $98.71 | $1,974,295 | 163,604 (Direct) |
View |
| 2020-10-07 Sale |
2020-10-09 4:05 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $99.17 | $495,850 | 183,604 (Direct) |
View |
| 2020-08-19 Sale |
2020-08-21 4:22 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $75.02 | $1,500,438 | 188,604 (Direct) |
View |
| 2020-05-12 Sale |
2020-05-14 4:38 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $64.67 | $1,293,427 | 208,604 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-01 Option Award |
2022-03-03 7:58 pm |
N/A 2032-03-01 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO AND PRESIDENT |
22,500 | $0 | 210,948 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 4:18 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
30,000 | $0 | 401,351 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 4:18 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
7,500 | $1.87 | 401,351 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 4:18 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
22,500 | $15.01 | 401,351 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:03 pm |
N/A 2026-02-03 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $0 | 288,448 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:03 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $15.01 | 288,448 (Direct) |
View |
| 2021-08-26 Exercise |
2021-08-30 4:04 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
16,000 | $0 | 331,351 (Direct) |
View |
| 2021-08-26 Exercise |
2021-08-30 4:04 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
16,000 | $1.87 | 331,351 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-23 4:24 pm |
N/A 2026-02-03 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
25,000 | $0 | 436,351 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-23 4:24 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
7,500 | $1.87 | 436,351 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-23 4:24 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
17,500 | $15.01 | 436,351 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:44 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 6:27 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
18,188 | $0 | 18,188 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 6:02 pm |
N/A 2026-02-03 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
25,000 | $0 | 461,351 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 6:02 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
7,500 | $1.87 | 461,351 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 6:02 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
17,500 | $15.01 | 461,351 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 5:48 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
10,000 | $8.8 | 179,618 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 5:48 pm |
N/A 2025-02-10 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
10,000 | $0 | 179,618 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:26 pm |
N/A 2031-03-01 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
120,000 | $0 | 261,434 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:04 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $8.8 | 158,604 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:04 pm |
N/A 2025-02-10 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $0 | 158,604 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 4:22 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $8.8 | 163,604 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 4:22 pm |
N/A 2025-02-10 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $0 | 163,604 (Direct) |
View |
| 2020-10-07 Exercise |
2020-10-09 4:05 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $8.8 | 183,604 (Direct) |
View |
| 2020-10-07 Exercise |
2020-10-09 4:05 pm |
N/A 2025-02-10 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
5,000 | $0 | 183,604 (Direct) |
View |
| 2020-08-20 Option Award |
2020-08-21 6:27 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
40,127 | $0 | 40,127 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 4:22 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $8.8 | 188,604 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 4:22 pm |
N/A 2025-02-10 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $0 | 188,604 (Direct) |
View |
Ownership |
2020-08-20 8:32 pm |
N/A 2030-07-28 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
0 | $0 | 31,349 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:21 pm |
N/A 2030-06-04 |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
18,188 | $0 | 18,188 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-14 4:38 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $8.8 | 208,604 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-14 4:38 pm |
N/A 2025-02-10 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO and President |
20,000 | $0 | 208,604 (Direct) |
View |